How to reduce clinical risk through corporate and individual indemnity By: Ross Clark | Post date: 20/12/2017 | Time to read article: 1 mins The information within this article was correct at the time of publishing. Last updated 14/11/2018 () ★ Communicate Marketing & business development New care models One of the key issues from our research, was the challenge related to corporate indemnity and where clinical accountability sits – with the individual or the corporate entity? Ross Clark, Partner at Hempsons, discusses the need for organisations to manage clinical risk with the correct indemnity products. Transcript Corporate indemnity and clinical liability and clinical oversight is a common question when GPs form provider groups or provider organisations, who’s responsible for the clinical oversight? I say to federations and groups, actually, you’re in an unusual sector because each individual clinician carries his or her own indemnity policy such as an MPS policy. The company will also look at its own insurance products for director’s and officer’s liability and employer’s liability et cetera so there’s a range of insurance products there but the key risk is clinical risk and that’s covered off with the individual policies but the organisation needs to have oversight to manage effectively and reduce the clinical risk across the organisation. Share this article Share Tweet Medical Protection Expert Ross Clark Ross Clark is head of services for the North at Hempsons Healthcare Solicitors. He works with all aspects of GP primary care, with a current focus on the establishment of GP Federations and Provider Organisations across England.